Immediate Impact
32 standout
Citing Papers
Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
2025 Standout
Breast cancer: pathogenesis and treatments
2025 Standout
Works of Thomas Michaeli being referenced
Overall Survival, Progression-Free Survival, and Tumor Response Benefit Supporting Initial US Food and Drug Administration Approval and Indication Extension of New Cancer Drugs, 2003-2021
2022
Prostate cancer follow-up costs in Germany from 2000 to 2015
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas Michaeli | 227 | 71 | 24 | 51 | 39 | 422 | |
| Daniel Tobias Michaeli | 278 | 72 | 34 | 53 | 48 | 505 | |
| Cathy Anne Pinto | 157 | 119 | 86 | 27 | 29 | 489 | |
| Annette Conrads‐Frank | 138 | 26 | 30 | 61 | 35 | 442 | |
| Saskia de Groot | 162 | 38 | 26 | 112 | 35 | 425 | |
| Prasun Subedi | 137 | 29 | 53 | 78 | 21 | 413 | |
| Andres F. Espinoza | 90 | 97 | 16 | 84 | 40 | 392 | |
| Joanna P. MacEwan | 114 | 21 | 33 | 57 | 53 | 373 | |
| Jessie Ehrisman | 53 | 75 | 26 | 90 | 27 | 449 | |
| Di Sun | 84 | 49 | 17 | 28 | 41 | 443 | |
| Zhimin Yang | 71 | 31 | 10 | 125 | 24 | 375 |
All Works
Loading papers...